EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bleomycin-Induced Pulmonary Fibrosis in Transgenic Mice Carrying the Human MUC5B rs35705950 Variant

Suphachai Tharavecharak, Hajime Fujimoto, Taro Yasuma, Corina N D'Alessandro-Gabazza iD, Masaaki Toda, Atsushi Tomaru, Haruko Saiki, Mei Uemura, Yurie Kogue iD, Toshiyuki Ito, Kazuki Furuhashi, Tomohito Okano und 7 weitere

Cells · 2024

DOI: 10.3390/cells13181523 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Suphachai Tharavecharak und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Faculty and Graduate School of Medicine, Mie University, Edobashi 2-174, Tsu 514-8507, Mie, Japan. Hauptthemen laut MEDLINE: Bleomycin, Mucin-5B, Mice, Transgenic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic pulmonary fibrosis (IPF) is a progressive, often fatal lung disease characterized by tissue scarring and declining lung function. The MUC5B promoter polymorphism rs35705950, a significant genetic predisposition for IPF, paradoxically associates with better survival and slower disease progression than other IPF genotypes. This study investigates the potential paradoxical protective effects of this MUC5B variant in lung fibrosis. For this purpose, we developed a transgenic mouse model overexpressing the human MUC5B rs35705950 variant in the proximal large airways. Lung fibrosis was induced through subcutaneous injection of bleomycin. Results demonstrated significantly reduced lung fibrosis severity in transgenic mice compared to wild-type mice, assessed by trichrome staining, Ashcroft scoring, and hydroxyproline levels. Additionally, transgenic mice showed significantly lower levels of inflammatory cells and cytokines (TNFα, IL-6, IFNγ) and growth factors (PDGF, CTGF, IL-13) in the bronchoalveolar lavage fluid and lung tissues. There was also a significant decrease in mRNA expressions of fibrosis-related markers (periostin, fibronectin, Col1a1). In summary, this study reveals that mucin overexpression related to the MUC5B rs35705950 variant in the large airways significantly attenuates lung fibrosis and inflammatory responses in transgenic mice. These findings suggest that the rs35705950 variant modulates inflammatory and fibrotic responses in the proximal airways, which may contribute to the slower disease progression observed in IPF patients carrying this variant. Our study offers a possible explanation for the paradoxical beneficial effects of the MUC5B variant despite its role as a significant predisposing factor for IPF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BleomycinMucin-5BMice, TransgenicAnimalsHumansMicePulmonary FibrosisCytokinesLungIdiopathic Pulmonary FibrosisDisease Models, AnimalBronchoalveolar Lavage Fluid

Stichwörter der Autor:innen

MUC5Binflammationpulmonary fibrosisrs35705950

Substanzen

BleomycinMucin-5BMUC5B protein, humanCytokines

Autor:innen und Institutionen

  • Department of Immunology, Faculty and Graduate School of Medicine, Mie University, Edobashi 2-174, Tsu 514-8507, Mie, Japan.
  • Department Pulmonary and Critical Care Medicine, Faculty and Graduate School of Medicine, Mie University, Edobashi 2-174, Tsu 514-8507, Mie, Japan.
  • Microbiome Research Center, Mie University, Edobashi 2-174, Tsu 514-8507, Mie, Japan.
  • Department of Diabetes, Endocrinology and Metabolism, Faculty and Graduate School of Medicine, Mie University, Edobashi 2-174, Tsu 514-8507, Mie, Japan.
  • Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
  • Department of Microbiology and Molecular Genetics, Mie University Graduate School of Medicine, Tsu 514-8507, Mie, Japan.

ORCID-Profile: Corina N D'Alessandro-Gabazza, Yurie Kogue, Tetsuya Nosaka, Esteban C Gabazza

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Tharavecharak, S., Fujimoto, H., Yasuma, T., D'Alessandro-Gabazza, C. N., Toda, M., Tomaru, A., Saiki, H., Uemura, M., Kogue, Y., Ito, T., Furuhashi, K., Okano, T., Takeshita, A., Nishihama, K., Ono, R., Hataji, O., Nosaka, T., Kobayashi, T., & Gabazza, E. C. (2024). Bleomycin-Induced Pulmonary Fibrosis in Transgenic Mice Carrying the Human MUC5B rs35705950 Variant. Cells. https://doi.org/10.3390/cells13181523

Vancouver

Tharavecharak S, Fujimoto H, Yasuma T, D'Alessandro-Gabazza CN, Toda M, Tomaru A, et al. Bleomycin-Induced Pulmonary Fibrosis in Transgenic Mice Carrying the Human MUC5B rs35705950 Variant. Cells. 2024. doi:10.3390/cells13181523

BibTeX
@article{Tharavecharak2024,
  author = {Tharavecharak, Suphachai and Fujimoto, Hajime and Yasuma, Taro and D'Alessandro-Gabazza, Corina N and Toda, Masaaki and Tomaru, Atsushi and Saiki, Haruko and Uemura, Mei and Kogue, Yurie and Ito, Toshiyuki and Furuhashi, Kazuki and Okano, Tomohito and Takeshita, Atsuro and Nishihama, Kota and Ono, Ryoichi and Hataji, Osamu and Nosaka, Tetsuya and Kobayashi, Tetsu and Gabazza, Esteban C},
  title = {Bleomycin-Induced Pulmonary Fibrosis in Transgenic Mice Carrying the Human MUC5B rs35705950 Variant},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13181523}
}
Kostenlos starten →